Skip to main content

Table 4 Secondary outcomes by group

From: Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial

 

Group R

Group D

Relative risk (95% CI)

Mean differences (95% CI)

PONV *

3 (3.7)

14 (16.9)

0.22 (0.06–0.73)

 

Pain NRS-11 score ≥ 4

33 (40.2)

42 (50.6)

0.80 (0.57–1.12)

 

Administration of rescue analgesics in the PACU

23 (28.0)

29 (34.9)

0.80 (0.51–1.26)

 

Intraoperative hypotension

13 (15.9)

17 (20.5)

0.77 (0.40–1.49)

 

PACU length of stay, min (IQR)

30 (30–35)

30 (30–30)

  

Time to extubation, sec (SD)†

862.0 (292.8)

476.7 (128.6)

 

385.3 (315.4–455.3)

Time to discharge to the PACU, sec (SD)†

963.5 (306.8)

548.6 (127.0)

 

414.9 (342.2–487.6)

  1. Presented in numbers with percentages in parentheses; * indicates P < 0.05, † indicates P < 0.001; CI confidence interval, PACU postoperative anesthetic care unit, PONV postoperative nausea and vomiting, NRS numeric rating scale